[A Case of Long-Term Survival after Resection of Postoperative Lung Metastasis from Pancreatic Cancer].

Q4 Medicine
Yoshiteru Katsura, Koji Hayashi, Narumi Sawamura, Satomi Sakai, Sakina Hashizume, Ryuta Ueda, Masahiro Koh, Yoshiki Taniguchi, Akio Hara, Naomi Urano, Hiroshi Takeyama, Setsuko Yoshioka, Hideoki Yokouchi, Kazuhiro Nishikawa, Shu Okamura
{"title":"[A Case of Long-Term Survival after Resection of Postoperative Lung Metastasis from Pancreatic Cancer].","authors":"Yoshiteru Katsura, Koji Hayashi, Narumi Sawamura, Satomi Sakai, Sakina Hashizume, Ryuta Ueda, Masahiro Koh, Yoshiki Taniguchi, Akio Hara, Naomi Urano, Hiroshi Takeyama, Setsuko Yoshioka, Hideoki Yokouchi, Kazuhiro Nishikawa, Shu Okamura","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Pancreatic cancer has an extremely poor prognosis due to recurrence in the early postoperative period. We report here a case of long-term survival after radical pancreatic cancer resection for lung metastasis. A 63-year-old man was found to have a pancreatic head mass during abdominal ultrasound examination due to an elevated CA19-9 level. He was referred to our department with a diagnosis of pancreatic head cancer (cStage ⅡB), and pancreatoduodenectomy was performed. The pathology results showed a diagnosis of pancreatic head cancer (pStage ⅡB), and GEM (1,000 mg/m2) was administered for 6 months (6 courses) as postoperative adjuvant therapy. Two and a half years after surgery, a nodule appeared in the lower lobe of the right lung (S10) on CT. Although the nodule had been gradually increasing, it was unclear whether it was a primary lung cancer or a lung metastasis of pancreatic cancer. A wedge resection of the lower lobe of the right lung was performed 3 years and 3 months after the initial surgery to confirm the diagnosis. The pathology results were consistent with lung metastasis of pancreatic cancer, and the patient was diagnosed as a case of recurrent pancreatic cancer. TS-1 (100 mg/day) was administered for 6 months (4 courses) as postoperative adjuvant therapy. The patient is currently under outpatient follow-up with no recurrence, 6 years and 1 month after the initial surgery and 3 years and 11 months after the recurrence surgery.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"53 4","pages":"290-292"},"PeriodicalIF":0.0000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Pancreatic cancer has an extremely poor prognosis due to recurrence in the early postoperative period. We report here a case of long-term survival after radical pancreatic cancer resection for lung metastasis. A 63-year-old man was found to have a pancreatic head mass during abdominal ultrasound examination due to an elevated CA19-9 level. He was referred to our department with a diagnosis of pancreatic head cancer (cStage ⅡB), and pancreatoduodenectomy was performed. The pathology results showed a diagnosis of pancreatic head cancer (pStage ⅡB), and GEM (1,000 mg/m2) was administered for 6 months (6 courses) as postoperative adjuvant therapy. Two and a half years after surgery, a nodule appeared in the lower lobe of the right lung (S10) on CT. Although the nodule had been gradually increasing, it was unclear whether it was a primary lung cancer or a lung metastasis of pancreatic cancer. A wedge resection of the lower lobe of the right lung was performed 3 years and 3 months after the initial surgery to confirm the diagnosis. The pathology results were consistent with lung metastasis of pancreatic cancer, and the patient was diagnosed as a case of recurrent pancreatic cancer. TS-1 (100 mg/day) was administered for 6 months (4 courses) as postoperative adjuvant therapy. The patient is currently under outpatient follow-up with no recurrence, 6 years and 1 month after the initial surgery and 3 years and 11 months after the recurrence surgery.

[1例胰腺癌术后肺转移切除后的长期生存]。
胰腺癌术后早期易复发,预后极差。我们在此报告一例胰腺癌根治性切除肺转移后的长期生存。一名63岁男性在腹部超声检查中发现胰腺头部肿块,原因是CA19-9水平升高。他被诊断为胰头癌(cStageⅡB)转介至我科,并行胰十二指肠切除术。病理诊断为胰头癌(pStageⅡB),术后给予GEM (1000 mg/m2)辅助治疗6个月(6个疗程)。术后两年半,CT示右肺下叶(S10)一结节。虽然结节逐渐增大,但尚不清楚是原发性肺癌还是胰腺癌的肺转移。在初次手术3年零3个月后进行了右肺下叶楔形切除术以确认诊断。病理结果符合胰腺癌肺转移,诊断为胰腺癌复发病例。TS-1 (100mg /天)作为术后辅助治疗给予6个月(4个疗程)。患者目前在门诊随访,术后6年1个月,复发术后3年11个月,无复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
337
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书